A cross-border investigation has traced a corporate labyrinth—stretching from Luxembourg to Bahrain to the Cayman Islands—back to Bahaa Hariri, with former P⁠M Fouad Siniora and billionaire Fouad Makhzoumi woven into the same web of companies, while Bahaa's name barely appears on a single document.

• Daraj's review of Luxembourg's commercial registry identifies Bahaa Hariri as the Ultimate Beneficial Owner of both "International Express Services" and "GES Overseas SARL"—yet his name is absent from annual reports, administrative amendments, and key company signatures.
• The same network connects to former P⁠M Siniora and Makhzoumi through a shared manager, Omar Ashur, who serves as CFO of Makhzoumi's companies while co-owning "Al-Huda Real Estate" alongside Bahaa Hariri and Siniora.
• Another recurring figure, Jamil Bayram—former Regional Manager at BankMed—also co-owns "Al-Huda Real Estate" and his name appears in Lebanese Ministry of Defense contracts from 2018, during Saad Hariri's government.
• The investigation is part of the OCCRP-coordinated OpenLux project; Bahaa Hariri did not respond to right-of-reply questions.

Why it matters: The investigation reveals how Lebanon's political and financial elite can structure cross-jurisdictional corporate ownership in ways that technically meet registration requirements while keeping the real power behind the paper trail almost invisible.

The pop star who traded stadiums for militant rallies and then spent over a decade hiding in a Palestinian refugee camp has been released on bail in Beirut, but the cases against him remain open and the probe continues.

• Chaker paid a combined bail of 500 million Lebanese pounds (approximately $5,500) across four security cases, with 200 million pounds assigned to the most serious charge—the 2013 Abra clashes in Sidon—according to judicial officials cited by the Associated Press.
• He had surrendered to Lebanese military intelligence last Oct⁠ober after 12 years as a fugitive, hiding in the Ein El Hilweh Palestinian refugee camp near Sidon; a military tribunal had sentenced him in absentia in 2020 to 22 years.
• The original sentence was dropped and a retrial was begun; during proceedings Chaker denied participating in the 2013 clashes, which killed more than a dozen soldiers and deepened sectarian tensions in Lebanon, according to L'Orient To⁠day.
• His co-accused, cleric Ahmad al-Assir, was convicted and sentenced to death in 2017 and remains on death row.

Zooming out: Chaker's case is a living archive of the Syrian war's spillover into Lebanon—sectarian street battles, fugitive years, and a judicial process that's still unresolved more than a decade later.

Since taking the Secretary-General post after the 2024 war gutted Hezbollah's first-tier leadership, Sheikh Naim Qassem has been navigating an internal battle over the party's future direction—and, according to political sources, it's getting louder.

• Two camps have emerged: one pushing for structural reform, new cadres, and revised working mechanisms after the war's heavy losses; the other insisting on preserving the traditional organizational model that has governed the party for decades.
• Qassem's new appointments and redistribution of responsibilities became flashpoints—supporters call it injecting fresh blood; opponents call it dismantling historical internal balances.
• The management of the relationship with Parliament Speaker Nabih Berri has also sparked debate, with critics arguing that Berri's prominent role in negotiations suggests the party's Secretary-General is being sidelined from political decision-making.

What to watch: Whether Qassem can consolidate his reform agenda or whether internal resistance forces a compromise will shape how Hezbollah repositions itself in Lebanon's new post-war political landscape.

German researchers have published long-term follow-up data on a therapeutic vaccine targeting aggressive brain tumors—and the numbers are cautiously encouraging for a disease that has resisted treatment for decades.

• In a study of 33 patients with high-grade astrocytomas, 66% were still alive after eight years, and in 42% of participants the tumor had not returned during that period, according to results published in Nature.
• The vaccine targets a specific genetic mutation found only in certain brain tumors, training the immune system to produce T cells and antibodies that attack abnormal tumor cells after standard radiochemotherapy.
• Researchers caution that conclusions from 33 patients are limited; a randomized controlled study with more than 200 patients is planned to begin in Mar⁠ch 2027, with reliable results not expected for roughly nine years.

What to watch: The 2027 randomized trial will be the real test of whether the vaccine's immune response holds across a larger population—and whether booster shots can extend the effect further.

A two-year joint investigation has resulted in charges against 37 people, including the imprisoned head of a major Indian criminal gang accused of orchestrating the 2023 assassination of a Canadian Sikh activist—a killing that sent Canadian-Indian diplomatic relations into a tailspin.

• Lawrence Bishnoi, jailed in India, was charged with directing the murder of Hardeep Singh Nijjar, who was fatally shot outside a temple in Canada in 2023; authorities say Bishnoi used smuggled phones and provided a co-conspirator with photos and addresses of the victim.
• Operation Hard Ball, coordinated by the FBI and Canada's RCMP, also seized roughly 1,000 kg of cocaine and a dozen firearms; seven fugitives remain at large in the US, two in India, and one in Europe.
• Local police in Surrey, British Columbia, recorded 131 extortion reports in 2026 alone, alongside 20 related shootings and two arsons linked to the broader criminal network.

The bigger picture: The case has become a test of how democracies respond when allegations of state-directed violence against diaspora dissidents collide with trade relationships and diplomatic partnerships.

The World Health Organization is sounding an alarm that cancer's projected surge isn't just a medical problem—it's an economic one, and the financial burden is already pushing patients in wealthy countries toward debt and interrupted lives.

• Global cancer cases could reach 35 million by 2050, up from 20.6 million to⁠day, according to a new WHO report, while tobacco use alone accounts for 30% of all cancer deaths, according to the National Cancer Institute.
• The US spent nearly $209 billion on cancer care in 2020—the highest of any country—yet approximately 45–60% of diagnosed patients globally experience what WHO calls "catastrophic health expenditure," leading to debt and food insecurity.
• WHO estimates that nearly 40% of new cancer cases are preventable by reducing exposure to modifiable risk factors, and calculates a social return of $9.50 for every dollar invested in prevention and control.

Zooming out: As aging populations and rising treatment costs converge globally, the gap between the pace of medical innovation and the ability of health systems—particularly in lower-income countries—to afford and deliver it is widening faster than the science.